Advancing research that bisphenol A, a chemical found in plastic bottles and food packaging, has minimal adverse health effects could play an important role in U.S. and European regulators’ decisions on the chemical’s use in the future.
The years-long study—called BPA CLARITY—aims to reconcile Food and Drug Administration findings that BPA is safe to use with studies from academic researchers that question whether BPA interferes with the production and function of hormones or contributes to infertility, breast cancer, or behavioral changes in children.
The premise of the research initiative is that by conducting studies of BPA under the same ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.